TL;DR:
- Non-melanoma skin cancers like BCC and SCC require tailored surgical approaches, often including Mohs surgery.
- Mohs micrographic surgery offers high cure rates and tissue preservation, especially for facial cancers.
- Accurate diagnosis and choosing specialized treatment centers are crucial for optimal outcomes and cosmetic results.
A diagnosis of basal or squamous cell carcinoma on your face brings two pressing questions at once: how serious is this, and will treatment affect how I look? These are not vanity concerns. They are entirely reasonable, and the answers depend heavily on which type of skin cancer you have. Non-melanoma skin cancers account for the vast majority of cases in the UK, yet patients are rarely given a clear breakdown of what each type means for their treatment pathway. This guide gives you exactly that, with a focus on facial cancers and the surgical options that protect both your health and your appearance.
Key Takeaways
| Point | Details |
|---|---|
| BCC and SCC are most common | Basal and squamous cell carcinomas make up the majority of facial skin cancers in the UK. |
| Mohs surgery preserves appearance | Mohs micrographic surgery is ideal for removing facial cancers while saving healthy tissue. |
| Choosing the right centre is vital | Expert, accredited surgeons ensure the best outcome for both cure rates and aesthetics. |
| Melanoma needs different care | Mohs is not routine for melanoma or other rare types; seek a specialised treatment team. |
How skin cancers differ: key criteria for patients
Not all skin cancers behave the same way, and that distinction matters enormously when you are considering treatment. The type of cancer determines how urgently you need to act, how likely it is to cause lasting harm, and which surgical approach will deliver the best outcome. For facial skin cancers in particular, the wrong treatment choice can leave lasting functional or cosmetic damage.
Skin cancers broadly fall into two categories: non-melanoma (which includes basal cell carcinoma and squamous cell carcinoma) and melanoma. Each has distinct behaviour, risk profile, and treatment requirements. Rarer types such as Merkel cell carcinoma, cutaneous lymphomas, and Kaposi sarcoma exist but are far less common.
When assessing any skin cancer, clinicians and patients alike should consider these key criteria:
- Cell of origin: Where in the skin layers did the cancer start? This shapes how it grows and spreads.
- Tendency to metastasise: Does it stay local, or can it travel to lymph nodes and organs?
- Likelihood of recurrence: Will it come back after treatment, and if so, how quickly?
- Suitability for tissue-sparing surgery: Can the cancer be removed with minimal loss of healthy tissue?
- Location on the face: High-risk zones (nose, eyelids, lips, ears) demand extra surgical precision.
Understanding your specific cancer type is not just useful background knowledge. It is the foundation of every treatment decision you and your surgeon will make together.
For patients with facial cancers, Mohs micrographic surgery has become a gold standard precisely because it addresses several of these criteria at once. It removes cancer layer by layer, checking margins in real time, which means maximum removal certainty with minimum loss of healthy tissue.
Basal cell carcinoma (BCC): most common and least aggressive
BCC is by far the most common skin cancer in the UK. It forms from basal cells, which sit in the deepest layer of the epidermis (the outer skin). It typically grows slowly and, crucially, rarely spreads to other parts of the body. That can make it sound harmless. It is not.
Left untreated on the face, BCC can burrow deeply into surrounding tissue, cartilage, and even bone. Areas like the nose, eyelids, and lips are particularly vulnerable to this kind of local destruction. The good news is that when caught and treated correctly, cure rates are excellent.
BCC is the most common UK skin cancer, making up nearly 75% of all cases. It often appears as a pearly or waxy bump, a flat flesh-coloured lesion, or a slightly bleeding sore that does not heal. On the face, it can be subtle and easy to dismiss.
Key features of BCC that matter for treatment:
- Growth pattern: Most BCCs are nodular and well-defined. However, infiltrative and micronodular subtypes have ill-defined edges that standard excision can miss.
- Recurrence risk: Incomplete removal is a major driver of recurrence, especially in cosmetically sensitive areas.
- High-risk zones: The nasolabial folds, inner corners of the eyes, and behind the ears are notorious for aggressive BCC behaviour.
Mohs micrographic surgery is a specialist technique specifically well-suited to BCC, especially on the face. It achieves the highest reported cure rates for primary BCC (around 99%) and recurrent BCC (around 95%), whilst preserving as much healthy tissue as possible.
Pro Tip: If your BCC is described as infiltrative, morphoeic, or recurrent, ask specifically about Mohs for BCC rather than accepting standard excision. These subtypes are poorly served by conventional surgery. You can also explore common misconceptions about the procedure to feel more prepared.
Squamous cell carcinoma (SCC): second most common, higher risk
SCC develops from squamous cells, which are found closer to the skin’s surface. It is the second most common skin cancer in the UK, accounting for roughly 20% of cases. Unlike BCC, SCC carries a meaningful risk of spreading to lymph nodes and beyond, which is why prompt, precise treatment is so important.
SCC arises from squamous cells and can present as a rough, scaly patch, a firm red nodule, or a new sore within an old scar. On the face, it most commonly appears on the lips, ears, and scalp. It can develop from a precancerous lesion called actinic keratosis (sun-damaged skin), which underlines how much cumulative UV exposure matters over a lifetime.
Here is how to think about the decision-making process for SCC treatment:
- Confirm the subtype: Desmoplastic and poorly differentiated SCCs behave more aggressively and require more advanced management.
- Assess the location: Facial SCCs, especially those near the H-zone (eyes, nose, lips, ears), carry higher recurrence risk.
- Review patient factors: Immunosuppressed patients (e.g., organ transplant recipients) have significantly higher SCC risk and worse outcomes from incomplete treatment.
- Choose the right surgery: Standard excision works for low-risk, small SCCs in safe locations. High-risk or recurrent SCCs need Mohs surgery and reconstruction.
- Plan ahead for reconstruction: Large facial SCCs often require plastic surgical repair. Discussing this before your procedure avoids unpleasant surprises.
Mohs surgery for high-risk SCC, recurrent cases, immunocompromised patients, and tumours in the facial H-zone is backed by clinical guidelines. It is not just a preference. It is the recommended standard where cure rates and cosmetic outcomes both matter.
Pro Tip: If you are immunosuppressed or have had an SCC recur, you may qualify as high-risk. Read the high-risk SCC treatment guide to understand what your care pathway should include.
Other rarer skin cancers: what facial patients should know
Whilst BCC and SCC account for the vast majority of facial skin cancers, a small number of patients receive diagnoses of rarer types. These include melanoma, Merkel cell carcinoma, cutaneous lymphomas, and Kaposi sarcoma. Each requires a different treatment approach, and it is important to understand why Mohs surgery is generally not part of that picture.
Rarer skin cancer types such as Merkel cell carcinoma, cutaneous lymphomas, and Kaposi sarcoma tend to be more aggressive and often require systemic treatments (immunotherapy, chemotherapy, or radiotherapy) alongside or instead of surgery. Melanoma, the most well-known of these, is staged and managed very differently from BCC or SCC.
| Cancer type | Typical behaviour | Is Mohs used? | Main treatment approach |
|---|---|---|---|
| BCC | Locally invasive, slow growing | Yes (gold standard) | Mohs surgery, excision |
| SCC | Can spread, moderate risk | Yes (high-risk cases) | Mohs, excision, radiotherapy |
| Melanoma | Aggressive, high spread risk | No | Wide local excision, immunotherapy |
| Merkel cell carcinoma | Rare, aggressive | No | Surgery, radiotherapy, immunotherapy |
| Cutaneous lymphoma | Variable, systemic | No | Systemic treatments, specialist MDT |
| Kaposi sarcoma | Variable, often multifocal | No | Systemic treatments, oncology team |
Melanoma is treated differently and Mohs surgery is not routinely indicated. This is because melanoma requires wide surgical margins and sentinel lymph node assessment, which Mohs is not designed to provide.
If you receive a diagnosis outside BCC or SCC, your priorities should be:
- Rapid referral to a multidisciplinary team (MDT) at a specialist centre
- Staging investigations to understand spread
- Discussion of systemic treatment options alongside surgical ones
- Psychological support, as rarer diagnoses often come with greater uncertainty
For patients who do have BCC or SCC, understanding these rarer types helps you ask the right questions and appreciate why your surgeon’s approach is tailored specifically to your situation. You can explore the full range of skin cancer treatments to see where your diagnosis fits within the broader picture.
Why choosing the right treatment centre changes everything
Most guides to skin cancer types stop at the diagnosis. Here is what they do not tell you: the centre you choose for treatment matters just as much as catching the cancer early. This is especially true for facial BCC and SCC.
A surgeon with dual training in Mohs surgery and plastic surgery is not a luxury. It is the combination that allows the procedure and the reconstruction to be planned together, in the room, on the same day. That matters when a tumour sits near your eyelid or the tip of your nose. Standard excision by a general surgeon, even a skilled one, cannot offer the same real-time margin checking or the same aesthetic repair planning.
Patients seeking Mohs for facial skin cancer should prioritise BAD-accredited centres, expect a same-day procedure with high cure rates, and discuss facial reconstruction options before surgery begins, not after.
Do not be afraid to ask your surgeon direct questions: Where did you train? How many Mohs cases do you perform per year? What reconstruction options will you use if margins are wide? A surgeon confident in their results will welcome those questions.
Next steps: expert support and Mohs surgery options in the UK
If you or someone close to you has been diagnosed with BCC or SCC on the face, the most important step you can take right now is to access expert advice from a surgeon with specific Mohs and facial reconstruction training.
At mohssurgeon.co.uk, Miss Rakhee Nayar offers precisely that combination. With dual specialisation in plastic surgery and Mohs surgery, she treats patients at her clinic in North West England, as well as accepting e-consultations from across the UK and internationally. Whether you are seeking a first opinion, a second opinion, or simply want to understand your options, the right information makes a meaningful difference. Start with our skin cancer detection service or explore detailed Mohs surgery information and facial reconstruction surgery options to find the pathway that suits your needs.
Frequently asked questions
What are the main differences between BCC and SCC?
BCC is the most common UK skin cancer and grows slowly with minimal risk of spreading, whilst SCC is the second most common and carries a higher risk of spreading to lymph nodes, particularly when located on the face.
Why is Mohs surgery preferred for facial BCC and some SCC?
Mohs surgery allows real-time checking of all surgical margins whilst removing the least possible amount of healthy tissue, giving facial patients the highest combination of cure rate and cosmetic preservation available.
Is Mohs surgery offered on the NHS for all skin cancers?
NHS provision covers Mohs mainly for high-risk facial BCC and selected SCC cases, but NHS availability is limited and waiting times can be lengthy, making private treatment a faster route for many patients.
Can Mohs surgery be used for melanoma?
No. Mohs is not routinely used for melanoma, which requires wide local excision and often sentinel lymph node biopsy as part of a different treatment pathway.
Recommended
- High-risk skin cancer: Expert treatment guide for UK patients
- Skin Cancer Detection – Expert Mohs Surgery | UK
- How to identify basal cell carcinoma on the face: UK guide
- How to Spot Skin Cancer Symptoms on the Face – Expert Mohs Surgery | UK
Filed under Skin Cancer Explained
